Cancer Society: eCigarette Study Proves Nothing
Statement from Russ Sciandra, NYS Director of Advocacy, American Cancer Society of NY & NJ in response to new study on e-cigarettes
“There are simply too many unknowns when it comes to e-cigarettes. While a new study out today (Electronic Cigarettes as a Smoking Cessation Tool) touts e-cigarettes as a potential smoking cessation device, there still is no scientific evidence that e-cigarettes are a safe substitute for traditional cigarettes or an effective smoking cessation tool. In effect, this study proves nothing.
First, more than half those surveyed did not respond. It's reasonable to assume that nonresponders are more likely continuing smokers, and in fact would be counted that way in many studies. This lowers the "success" rate from 30% to 15%.
Second, cessation is based only on self-report There is no biochemical (or any other kind) of independent validation. This biases the findings toward cessation.
Finally, it's based on only one brand of e-cigarette and studies have shown tremendous variability in the nicotine delivery and other factors between and within brands.
We certainly support the development of therapies that help people quit smoking. If these devices work as the manufacturers claim they do, we urge them to submit their products for clinical research and present the findings to the FDA to determine if they indeed should be classified as a smoking cessation product. In the meantime, New York State should absolutely halt the sale of these products to children and prevent their sale to adults until they're proven safe. ”
# # #
About the American Cancer Society
The American Cancer Society combines an unyielding passion with nearly a century of experience to save lives and end suffering from cancer. As a global grassroots force of more than three million volunteers, we fight for every birthday threatened by every cancer in every community. We save lives by helping people stay well by preventing cancer or detecting it early; helping people get well by being there for them during and after a cancer diagnosis; by finding cures through investment in groundbreaking discovery; and by fighting back by rallying lawmakers to pass laws to defeat cancer and by rallying communities worldwide to join the fight. As the nation’s largest non-governmental investor in cancer research, contributing about $3.4 billion, we turn what we know about cancer into what we do. As a result, more than 11 million people in America who have had cancer and countless more who have avoided it will be celebrating birthdays this year. To learn more about us or to get help, call us any time, day or night, at 1-800-227-2345 or visit cancer.org
New York Updates
- 3.26.15: Statement on Passage of Funding for Community Health Centers
- 3.11.15 Statement on Senate and Assembly Rejecting Funding Cuts to CSP
- 2.10.15: Cancer Patients and Survivors Travel to Albany
- 2.1.15: ACS CAN Criticizes Governor for Cuts to Life Saving Cancer Services
- 1.21.15 Statement on Governor Cuomo’s Proposed Regulation of e-Cigarettes
- 11.24.14 News Release: Palliative Care Collaborative Announced
- 11.20.14 ACS CAN Launches #FightSmokingNY Social Media Campaign
- New York City Lobbying & Legislative Consulting Contract RFP